Literature DB >> 8239621

Detection and characterization of mupirocin resistance in Staphylococcus aureus.

D A Janssen1, L T Zarins, D R Schaberg, S F Bradley, M S Terpenning, C A Kauffman.   

Abstract

Fourteen mupirocin-resistant Staphylococcus aureus strains were isolated over 18 months; 12 exhibited low-level resistance, while two showed high-level resistance. Highly mupirocin-resistant strains contained a large plasmid which transferred mupirocin resistance to other S. aureus strains and to Staphylococcus epidermidis. This plasmid and pAM899-1, a self-transferable gentamicin resistance plasmid, have molecular and biologic similarities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239621      PMCID: PMC188110          DOI: 10.1128/AAC.37.9.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  The value of nasal mupirocin in containing an outbreak of methicillin-resistant Staphylococcus aureus in an orthopaedic unit.

Authors:  S P Barrett
Journal:  J Hosp Infect       Date:  1990-02       Impact factor: 3.926

Review 2.  Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent.

Authors:  M W Casewell; R L Hill
Journal:  J Antimicrob Chemother       Date:  1987-01       Impact factor: 5.790

3.  Mupirocin-resistant Staphylococcus aureus.

Authors: 
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

4.  Conjugative R plasmids in antimicrobial resistance of Staphylococcus aureus causing nosocomial infections.

Authors:  D R Schaberg; G Power; J Betzold; B A Forbes
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

5.  Simple method for demonstrating small plasmid deoxyribonucleic acid molecules in oral streptococci.

Authors:  F L Macrina; P H Wood; K R Jones
Journal:  Appl Environ Microbiol       Date:  1980-05       Impact factor: 4.792

6.  Transfer of resistance plasmids from Staphylococcus epidermidis to Staphylococcus aureus: evidence for conjugative exchange of resistance.

Authors:  B A Forbes; D R Schaberg
Journal:  J Bacteriol       Date:  1983-02       Impact factor: 3.490

7.  Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.

Authors:  C Thornsberry; L K McDougal
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

8.  Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment.

Authors:  C A Kauffman; M S Terpenning; X He; L T Zarins; M A Ramsey; K A Jorgensen; W S Sottile; S F Bradley
Journal:  Am J Med       Date:  1993-04       Impact factor: 4.965

9.  Mupirocin treatment of nasal staphylococcal colonization.

Authors:  B E Scully; F Briones; J W Gu; H C Neu
Journal:  Arch Intern Med       Date:  1992-02

10.  Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak.

Authors:  R L Hill; G J Duckworth; M W Casewell
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

View more
  14 in total

1.  In vitro activity of mupirocin against methicillin-resistant Staphylococcus aureus isolated from a hospital in Spain.

Authors:  T Alarcón; D Domingo; M C del Rey; S López; I Sánchez; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

2.  Characterization of mupirocin-resistant Staphylococcus aureus from different geographic areas.

Authors:  M A Ramsey; S F Bradley; C A Kauffman; T M Morton; J E Patterson; D R Reagan
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

3.  Antibacterial activity of REP8839, a new antibiotic for topical use.

Authors:  Ian A Critchley; Casey L Young; Kimberley C Stone; Urs A Ochsner; Joseph Guiles; Ted Tarasow; Nebojsa Janjic
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis.

Authors:  Julian G Hurdle; Alex J O'Neill; Lona Mody; Ian Chopra; Suzanne F Bradley
Journal:  J Antimicrob Chemother       Date:  2005-11-07       Impact factor: 5.790

5.  Conjugative transfer of high-level mupirocin resistance from Staphylococcus haemolyticus to other staphylococci.

Authors:  E E Udo; L E Jacob; E M Mokadas
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

6.  Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Eileen Ingham; Colin Fishwick; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use.

Authors:  Erik Bathoorn; David J Hetem; Jeriela Alphenaar; Johannes G Kusters; Marc J M Bonten
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

8.  Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.

Authors:  Andrew E Simor; Tammy L Stuart; Lisa Louie; Christine Watt; Marianne Ofner-Agostini; Denise Gravel; Michael Mulvey; Mark Loeb; Allison McGeer; Elizabeth Bryce; Anne Matlow
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

9.  Characterization of a conjugative staphylococcal mupirocin resistance plasmid.

Authors:  T M Morton; J L Johnston; J Patterson; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

10.  SB 205952, a novel semisynthetic monic acid analog with at least two modes of action.

Authors:  J M Wilson; B Oliva; R Cassels; P J O'Hanlon; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.